• About us
  • People
  • Expertise
    • Sectors
        • Technology, media & communications Technology, media & communications
        • Private Wealth Private wealth
        • Real estate, infrastructure & energy
        • Life sciences & healthcare icon Life sciences & healthcare
        • Aerospace & defence
        • Automotive & mobility
        • Business & professional services
        • Chemicals
        • Consumer & retail
        • Financial institutions & insurance
        • Hotels, hospitality & leisure
        • Logistics & transport
        • Manufacturing & industrials
        • Public services & education
    • Legal services
        • Artificial intelligence
        • Banking & finance
        • Brands & advertising
        • Commercial & consumer contracts
        • Competition, EU & trade
        • Copyright & media law
        • Corporate crime & compliance
        • Corporate/M&A & capital markets
        • Data & cyber
        • Disputes & investigations
        • Employment, pensions & mobility
        • Environmental, planning & regulatory
        • Environmental, social & governance (ESG)
        • Intellectual property
        • Information technology
        • Patents & innovation
        • Private client
        • Private equity
        • Projects, energy & infrastructure
        • Real estate & construction
        • Regulation
        • Restructuring & insolvency
        • Tax
        • Venture capital
  • Locations
    • Europe
        • Locations
        • Austria
        • Belgium
        • Czech Republic
        • France
        • Germany
        • Hungary
        • Italy
        • Netherlands
        • Poland
        • Portugal
        • Ireland
        • Slovakia
        • Spain
        • United Kingdom
        • Ukraine
          Groups & regions
        • CEE Turkish Desk
        • French German group
        • Our offices
    • Middle East & Africa
        • Locations
        • Middle East
        • UAE
          Groups
        • Africa group
        • Israel group
        • Our offices
    • Americas
        • Locations
        • Latin America
        • USA
          Groups
        • Brazil group
        • Our offices
    • Asia
        • Locations
        • Asia
        • China
        • South Korea
          Groups
        • India group
        • Japan group
        • Our offices
  • Insights
    • Insights
        • Featured Topics
        • Artificial intelligence
        • Data Centre Expertise
        • The EU Whistleblower Directive
        • German Supply Chain Act
        • Unified Patent Court
          Content hub
        • Global Data Hub
        • Interface: tech, IP and media law
        • Podcasts
        • Synapse
        • Browse all insights
    • In focus
        • AI
        • Dealonomics
        • Disputes
        • Intellectual property
        • MENA
        • Regulation
        • Browse in focus
    • Events
        • In person
        • Online
        • Browse all events
    • News
        • Media centre
        • Work highlights
        • Firm news
        • Browse all news
  • Careers
  • EN
    • English
    • 中文(简体)
    • Français
    • Deutsch
  • Home
  • People
  • Bella Thornton-Clark
Bella Thornton-Clark
Bella Thornton-Clark

Bella Thornton-Clark

Senior Associate

  • London UK
  • San Francisco USA
Contact Me Today
+44 20 7300 7000
vCard
Email me Call me

Bella regularly advises companies ranging from early stage start-ups to late stage unicorns on a wide range of corporate matters. Bella started her career as a venture capital lawyer in San Francisco before moving to London. Her clients value her commercial insight into trends and norms in the Californian start-up market. Bella's practice is focused on technology start-ups with particular emphasis on consumer goods, SaaS, healthcare, and fintech.  

 

Expertise

Services and Groups

Venture capital
Private equity
Corporate/M&A & capital markets
Environmental, social & governance (ESG)
Corporate venturing
Exit strategies (venture capital)
Employee and management participation
Financing rounds (Seed, subsequent and growth financing) equity and non-equity instruments
Start-up advice
VC funds formation
M&A

Sectors

Technology, media & communications
Life sciences & healthcare
Fintech
Software
Biotech
Our USA offering

Over the past 10 years, we've built a trusted legal team in San Francisco, focused on technology, media and communciation, life sciences and healthcare, real estate, private wealth, and private equity. Supported by colleagues in the UK and Europe, we also offer deep expertise in M&A, international growth, commercial deals, and data privacy.

Find out more

CV

Since 2024 Senior Associate, Taylor Wessing
2022 - 2024 Associate, Taylor Wessing
2020 - 2022 Associate, Gunderson Dettmer, San Francisco
2019 - 2020 Associate, Kirkland & Ellis, San Francisco
2019 Admission to California Bar
2019 J.D. University of Texas School of Law

Career

Since 2024 Senior Associate, Taylor Wessing
2022 - 2024 Associate, Taylor Wessing
2020 - 2022 Associate, Gunderson Dettmer, San Francisco
2019 - 2020 Associate, Kirkland & Ellis, San Francisco

Education

2019 Admission to California Bar
2019 J.D. University of Texas School of Law

Experience

Blue Earth Therapeutics on the closing of US$76.5 million Series A funding

We have advised Blue Earth Therapeutics and its management on the closing of US$76.5 million Series A funding. The new funding comes from a broad spectrum of experienced biotech investors and enables Blue Earth Therapeutics to further advance its clinical stage prostate-specific membrane antigen-targeted radioligand therapies.

Press release
Ross McNaughton
Bella Thornton-Clark

Advising gene therapy company AlveoGene on its complex spinout and launch investment

We have advised AlveoGene, a new UK gene therapy company on its complex spinout from the Gene Therapy Consortium of Imperial College and the Universities of Oxford and Edinburgh focusing on rare respiratory diseases, as well as on its seed round investment.

Press release
Ross McNaughton
Bella Thornton-Clark

Bella 's news & insights

View Bella 's insights
Skyline view of traffic
Click here to find out more
Corporate/M&A & capital markets

Advising EpilepsyGTx on its US$33 million Series A financing

10 December 2025

by multiple authors

Glass.Mapper.Sc.Fields.Image?.Alt
Corporate/M&A & capital markets

Advising on £40 million growth investment into Osprey Flight Solutions

9 September 2025

by multiple authors

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Corporate/M&A & capital markets

Blue Earth Therapeutics raises US$76.5 million Series A funding

30 October 2024

by Ross McNaughton and Bella Thornton-Clark

Click here to find out more
View Bella 's insights

Related news & insights

Hand writing on post-it notes
Corporate/M&A & capital markets

Taylor Wessing advises Hypax on the carve-out acquisition of the WOLF-Garten business from Stanley Black & Decker

28 January 2026

by multiple authors

Click here to find out more
Patterned pills
Life sciences & healthcare

Life Sciences Made in Europe – The European Commission’s Life Sciences Strategy 2030

27 January 2026
In-depth analysis

by Irina Rebin

Click here to find out more
Up Arrow
Corporate/M&A & capital markets

Advising Toho Global on its acquisition of Anime Limited

27 January 2026

by multiple authors

Click here to find out more
Overhead view of scientist using centrifuge machine
Life sciences & healthcare

Research and innovation as a competitive advantage – Legal framework for Life Sciences made in Europe

27 January 2026
In-depth analysis

by Irina Rebin

Click here to find out more
Blood samples
Life sciences & healthcare

Adoption of Commission Implementing Regulation (EU) 2025/2086: New Rules on the Joint Clinical Assessment of Medical Devices and In Vitro Diagnostic Medical Devices

23 January 2026
Briefing

by Irina Rebin and Daniel Dietrich

Click here to find out more
Escalator
Consumer & retail

Consumer and Retail in the News

23 January 2026
Quick read

by multiple authors

Click here to find out more
Low Angle View Of Flags Waving
Logistics & transport

EU Inc.: Founders and companies with expansion plans must now think strategically

23 January 2026
Quick read

by Dr. Benedikt Groh and Fritz Krings

Click here to find out more
Technology, media & communications

UK Online Safety Act fees regime kicks off – initial notifications due by 11 April 2026

22 January 2026
Quick read

by Debbie Heywood

Click here to find out more
Working Data Centre
Technology, media & communications

Ofcom's guidance on online safety for women and girls and UK government strategy

22 January 2026
Briefing

by Debbie Heywood

Click here to find out more
Office facade reflection
Life sciences & healthcare

Advising Nuclera on its extended Series C funding to US$87 million

22 January 2026

by Ross McNaughton and Oli Denne

Click here to find out more
View all insights

Related people

UK
Global

Ann Casey

Partner

London
+44 20 7300 4750
Email me
View profile
Curtis Anderson

Curtis Anderson

Associate

London
+44 20 7300 7000
Email me
View profile
Howard Palmer

Howard Palmer

Partner

London
+44 20 7300 4819
Email me
View profile
Dillan Madhani

Dillan Madhani

Associate

London
+44 20 7300 7000
Email me
View profile
Siobhán Langwade

Siobhán Langwade

Partner

London
+44 20 7300 7019
Email me
View profile

Edward Waldron

Partner

London
+44 (0)20 7300 4968
Email me
View profile
Alexandra Boreham

Alexandra Boreham

Associate

London
+44 20 7300 7000
Email me
View profile
Graham Samuel-Gibson

Graham Samuel-Gibbon

Partner

London
+44 20 7300 4916
Email me
View profile
James Goold

James Goold

Partner

London
+44 20 7300 4207
Email me
View profile
Philip Shepherd

Philip Shepherd

Partner

London
+44 20 7300 4655
Email me
View profile
Full team
Tillmann Pfeifer

Dr. Tillmann Pfeifer

Partner

Hamburg
+49 40 36803 0
Email me
View profile
Nicola Caton

Nicola Caton

Senior Associate

London
+44 20 7300 7000
Email me
View profile

Clover May

Associate

London
+44 20 7300 7000
Email me
View profile
Graham Samuel-Gibson

Graham Samuel-Gibbon

Partner

London
+44 20 7300 4916
Email me
View profile

Miriam Tigges, LL.M. (Medizinrecht)

Senior Associate

Duesseldorf
+49 211 8387 0
Email me
View profile
Kešnerová-Kristína

Kristína Kešnerová, LL.M.

Associate

Bratislava
+421 2 52 63 28 04
Email me
View profile

Dr. Verena Ritter-Döring

Partner

Frankfurt
+49 69 97130 0
Email me
View profile
Samy Elsheikh

Samy Elsheikh

Senior Associate

Dubai
+971 43 09 1013
Email me
View profile
Torsten Braner

Torsten Braner, LL.M.

Partner

Budapest
+36 1 3270407
Email me
View profile

Stella Yang

Counsel

Shanghai
+86 21 6247 7247
Email me
View profile
Full team

Meet me at

There are no upcoming events

See all events
Subscribe to our latest insights
  • About us
  • Campaigns and online tools
  • News
  • People
  • Expertise
  • Locations
  • Insights
  • Events
  • Media centre
  • Contact
  • Careers
  • Alumni
  • Data protection & privacy policy
  • Cookie policy
  • Legal and regulatory information
  • Regulatory information on costs
  • Complaints procedure for clients
  • Terms of use
  • Anti-slavery statement
  • Environmental
  • Scam emails

© Taylor Wessing